Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marjolein Peters

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
Seminars in Thrombosis and Hemostasis|October 1, 2003
Venous thromboembolic disease in childhoodC Heleen van Ommen, Marjolein Peters
Thrombosis Research|July 5, 2005
Acute pulmonary embolism in childhoodC Heleen Van Ommen, Marjolein Peters
European Journal of Pediatrics|July 30, 2011
The bleeding child. Part I: primary hemostatic disordersC Heleen van Ommen, Marjolein Peters
Critical Care Medicine|April 9, 2005
Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: a systematic reviewMarcel Levi, Marjolein Peters, Harry R Büller
Journal of Clinical and Translational Research|March 16, 2019
Administration of DDAVP did not improve the pharmacokinetics of FVIII concentrate in a clinically significant mannerJanneke I Loomans, Eva Stokhuijzen, Marjolein Peters, et al.
European Journal of Pediatrics|May 2, 2006
Identifying children with sickle cell anaemia in a non-endemic country: age at diagnosis and presenting symptomsXandra van den Tweel, Harriët Heijboer, Karin Fijnvandraat, et al.
BMJ (Clinical Research Ed.)|May 4, 2012
Diagnosis and management of haemophiliaKarin Fijnvandraat, Marjon H Cnossen, Frank W G Leebeek, et al.
Journal of Pediatric Hematology/Oncology|April 1, 2008
Nadroparin therapy in pediatric patients with venous thromboembolic diseaseC Heleen van Ommen, Erik-Jan van den Dool, Marjolein Peters
European Journal of Pediatrics|September 17, 2011
Clinical practice: the bleeding child. Part II: disorders of secondary hemostasis and fibrinolysisFemke van Herrewegen, Joost C M Meijers, Marjolein Peters, et al.
British Journal of Haematology|May 20, 2014
Effect of von Willebrand factor on inhibitor eradication in patients with severe haemophilia A: a systematic reviewAlice S van Velzen, Marjolein Peters, Johanna G van der Bom, et al.
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
Seminars in Thrombosis and Hemostasis|October 1, 2003
Venous thromboembolic disease in childhoodC Heleen van Ommen, Marjolein Peters
Thrombosis Research|July 5, 2005
Acute pulmonary embolism in childhoodC Heleen Van Ommen, Marjolein Peters
European Journal of Pediatrics|July 30, 2011
The bleeding child. Part I: primary hemostatic disordersC Heleen van Ommen, Marjolein Peters
Critical Care Medicine|April 9, 2005
Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: a systematic reviewMarcel Levi, Marjolein Peters, Harry R Büller
Journal of Clinical and Translational Research|March 16, 2019
Administration of DDAVP did not improve the pharmacokinetics of FVIII concentrate in a clinically significant mannerJanneke I Loomans, Eva Stokhuijzen, Marjolein Peters, et al.
European Journal of Pediatrics|May 2, 2006
Identifying children with sickle cell anaemia in a non-endemic country: age at diagnosis and presenting symptomsXandra van den Tweel, Harriët Heijboer, Karin Fijnvandraat, et al.
BMJ (Clinical Research Ed.)|May 4, 2012
Diagnosis and management of haemophiliaKarin Fijnvandraat, Marjon H Cnossen, Frank W G Leebeek, et al.
Journal of Pediatric Hematology/Oncology|April 1, 2008
Nadroparin therapy in pediatric patients with venous thromboembolic diseaseC Heleen van Ommen, Erik-Jan van den Dool, Marjolein Peters
European Journal of Pediatrics|September 17, 2011
Clinical practice: the bleeding child. Part II: disorders of secondary hemostasis and fibrinolysisFemke van Herrewegen, Joost C M Meijers, Marjolein Peters, et al.
British Journal of Haematology|May 20, 2014
Effect of von Willebrand factor on inhibitor eradication in patients with severe haemophilia A: a systematic reviewAlice S van Velzen, Marjolein Peters, Johanna G van der Bom, et al.
Pageof 7